Anthony Orlando
Medical · Woodbury, NJNPI 1457460743
Payments from drug & device makers
Across 256 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$681
- AbbVie$677
- Axsome Therapeutics, Inc.$669
- Novo Nordisk$443
- Lilly USA, LLC$399
- GSK$231
- plus $2K from 18 others
What the payments were for
- Food & beverage$4,715100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $681 |
| AbbVie | 47 | $677 |
| Axsome Therapeutics, Inc. | 19 | $669 |
| Novo Nordisk | 28 | $443 |
| Lilly USA, LLC | 25 | $399 |
| GSK | 15 | $231 |
| Pfizer | 11 | $217 |
| Idorsia Pharmaceuticals US Inc | 15 | $195 |
| Exact Sciences | 10 | $173 |
| Vanda Pharmaceuticals Inc. | 9 | $167 |
| Abbott | 7 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $111 |
| Johnson & Johnson | 5 | $90 |
| Merck | 6 | $88 |
| Astellas Pharma US Inc | 5 | $84 |
| Amgen | 5 | $79 |
| Boehringer Ingelheim | 5 | $73 |
| Boston Scientific | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,715 in reported general payments places this provider in the 85th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 52 | $63,758 |
| XareltoRivaroxaban | 50 | $63,372 |
| OzempicSemaglutide | 37 | $59,691 |
| MounjaroTirzepatide | 43 | $59,002 |
| FarxigaDapagliflozin Propanediol | 46 | $49,910 |
| EliquisApixaban | 46 | $44,533 |
| JardianceEmpagliflozin | 20 | $31,593 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 29 | $30,441 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $29,324 |
| Butalb-Acetaminoph-Caff-CodeinButalbit/Acetamin/Caff/Codeine | 12 | $17,137 |
| RybelsusSemaglutide | 11 | $16,788 |
| TradjentaLinagliptin | 11 | $15,454 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $11,428 |
| OxycontinOxycodone Hcl | 12 | $6,909 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 83 | $3,662 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $443 | $76,47848 claims |
| MerckJanuvia | $88 | $63,75852 claims |
| Johnson & JohnsonXarelto | $90 | $63,37250 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $681 | $61,33858 claims |
| Lilly USA, LLCMounjaro | $399 | $59,00243 claims |
| Boehringer IngelheimJardiance, Tradjenta | $73 | $47,04631 claims |
| PfizerEliquis | $217 | $44,53346 claims |
| GSKTrelegy Ellipta | $231 | $30,44129 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 573 medical providers in New Jersey.
Other medical in Woodbury
- Alison PietrasBrick$1.2M
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.